Drug Story
Drug Story
USA, New York
New York, New York
http://phentermine.awarenessnetworks.com/ online diet clinics that prescribe phentermine [url=http://cetirizine.awarenessnetworks.com/]cetirizine 20mg[/url] http://www.riffs.com/user/fioricet_online is fioricet before surgery ok [url=http://www.mlgpro.com/content/profile/4170068/FioricetOnline]discreet fioricet[/url] [url=http://ultram.awarenessnetworks.com/]ultram drug[/url] http://www.mlgpro.com/content/profile/4170068/FioricetOnline fioricet without a presciption celexa drug screens phentermine online http://celexa.awarenessnetworks.com/ cocitalopram celexa parmaceutical http://viagra.awarenessnetworks.com/ generic viagra 100mg http://bupropion.awarenessnetworks.com/ bupropion function medical [url=http://viagra.awarenessnetworks.com/]viagra where to buy in the united kingdom[/url] http://imitrex.awarenessnetworks.com/ imitrex health coverage plans 

Event Sponsors

Schedule of Presentations:

Friday, April 30, 2010
07:30:00 Registration Open
08:30:00 Chairperson’s Opening Remarks Peter J Hudson
08:40:00 KEYNOTE PRESENTATION Functional Proteomics for Biomarker and Target Discovery Joshua LaBaer
09:10:00 LOOKING TOWARD SCALE-UP AND THE CLINIC Efficient Cell-Mediated Cytotoxicity Using Bispecific Single Domain Antibodies for Cancer Therapy Patrick Chames
09:40:00 Shave Months off Clinical Development Timelines Using Simple and Rapid Selection of High-Performance Stable Mammalian Cells Expressing Recombinant Antibodies Andrew Sandford
10:10:00 Coffee Break in the Exhibit Hall
11:10:00 Improved Antibody-Drug Conjugates for Cancer Therapy Paul J Carter
11:40:00 NOVEL HOSTS AND NEW TECHNIQUES Production of Recombinant Antibody Fragments in Bacillus megaterium Stefan Dübel
12:10:00 Presentation I Balancing Power and Simplicity in Real Time-Label-Free Characterization and Selection of Antibodies
12:40:00 Presentation II
13:10:00 Break
13:30:00 Chairperson’s Remarks
13:35:00 Ribosome Display of Fc-1 and Selection of Improved Fc-1 Variants George V Thomas
14:05:00 In Vivo Imaging Technologies Using Engineered Antibodies Anna M Wu
14:35:00 Solutions Showcase I Transforming the Selection Process and IP Opportunities in Antibody Development Hans Johansson
14:50:00 Solutions Showcase II
15:05:00 Refreshment Break in the Exhibit Hall
15:50:00 Problem Solving Break-Out Sessions
16:50:00 Networking Cocktail Reception in the Exhibit Hall
Saturday, May 1, 2010
08:30:00 Chairperson’s Remarks
08:35:00 Panning a Human VH Phagemid-Based Phage Display Library for Non-Aggregating Binders Jamshid Tanha
09:05:00 HT Selection and Screening of scFv Antibodies Peter Pavlik
09:35:00 Metabolic Biotinylation of Recombinant Antibody by Biotin Ligase Retained in the Endoplasmic Reticulum Bhaswati Barat
10:05:00 Coffee Break in the Exhibit Hall
10:50:00 The Role of Transcription and Protein Misfolding in Sub-Optimal Expression: The Case of an Antibody-Interleukin Fusion Molecule Missag Parseghian
11:20:00 Synergistic CDR Mutagenesis and Clonal High- Throughput Screening Improves Antibody Binding Affinity without Display Panning Christian Votsmeier
12:00:00 New Presentation
12:00:00 New Presentation
12:00:00 New Presentation
12:00:00 New Presentation
12:00:00 New Presentation
12:00:00 New Presentation
Sunday, May 2, 2010
13:00:00 Registration Open CASE STUDIES-
14:00:00 Chairperson’s Remarks Lutz Jermutus
14:05:00 FEATURED PRESENTATION Respiratory Antibody Portfolio Case Study: Roland Kolbeck
14:50:00 Dll4 and Notch1 Antagonist Antibodies Inhibit Tumor Growth by Deregulating Angiogenesis Yan Wu
15:20:00 A Novel Bispecific Antibody Technology Chengbin Wu
15:50:00 Refreshment Break in the Exhibit Hall
16:15:00 Case Study: Antibodies as Protease Inhibitors Laetitia Devy
16:45:00 Development of a Portfolio of Therapeutic Antibodies for Oncology Combining Xenomouse and Display Technologies David Blakey
17:15:00 End of Day
Monday, May 3, 2010
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.